GRDX GridAI Technologies Corp. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Sep 18, 2026
$3.81
· of 52w range
· above low
· to high
$1.8752w low
$6.9352w high
Market Cap (MRQ)
$26M
P/E
-0.9
EPS
$-4.16
Revenue
$36.3K
your badges
52W Range
$2–$7
Analyst Rating
HOLD
Price Target
·
P/E
-0.9
ROE
-68.6%
Net Profit Margin
-17634.4%
Your badge strip is empty — pin a metric anywhere on this page.
GRDX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.81
Market Cap (MRQ)
$26M
P/E
-0.9
EPS
$-4.16
Revenue
$36.3K
ROE
-68.6%
Debt/Equity (MRQ)
0.1
52W Range
$2–$7
GRDX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Aug. 18, 2025 | 1-for-3 | Reverse |
| Dec. 18, 2023 | 1-for-20 | Reverse |
| Jan. 18, 2023 | 1-for-7 | Reverse |
| Aug. 26, 2022 | 1-for-30 | Reverse |
| Sept. 13, 2021 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$36.3K2018-12-31 → 2025-12-31
EPS$-4.162020-12-31 → 2025-12-31
Free Cash Flow·2016-12-31 → 2020-12-31
Net margin-17634.4%2025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | GRDX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.95Y avg ≈-2.4 | ≈-2.4 | · | · | |
| P/S | 444.0 | · | 20.1 | Overvalued | |
| P/B (MRQ) | 1.85Y avg ≈34.4 | ≈34.4 | 1.0 | Overvalued | |
| EV / EBITDA | -2.65Y avg ≈-11.0 | ≈-11.0 | · | · | |
| Price / Cash Flow | -2.85Y avg ≈-5.6 | ≈-5.6 | · | · | |
| EV / Revenue | 475.1 | · | · | · | |
| Price / Tangible Book (MRQ) | -4.5 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | GRDX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | -1813.6% | · | · | · | |
| Operating Margin | -19540.0% | · | -2151.2% | Weak | |
| EBITDA Margin | -17954.6% | · | -2151.2% | Weak | |
| Pretax Margin | -18316.8% | · | · | · | |
| Net Profit Margin | -17634.4% | · | -2017.1% | Weak | |
| ROA | -9.5%5Y avg ≈-118.7% | ≈-118.7% | -74.8% | Top tier | |
| ROE | -68.6%5Y avg ≈-1915.8% | ≈-1915.8% | -98.7% | Top tier | |
| ROIC | -24.7% | · | -66.2% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | GRDX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.15Y avg ≈0.2 | ≈0.2 | · | · | |
| Current Ratio (MRQ) | 0.25Y avg ≈1.5 | ≈1.5 | 3.4 | Low liquidity | |
| Quick Ratio | 0.15Y avg ≈0.5 | ≈0.5 | 2.5 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | GRDX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | Weak | |
| Receivables Turnover | 0.6 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-37.4%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2026 | May 27, 2026 | $-0.82 | — | — |
| Sept. 30, 2024 | $-1.77 | $-0.98 | -80.8% | |
| June 30, 2024 | $-10.11 | $-4.74 | -113.2% | |
| March 31, 2024 | $-1.92 | $-7.44 | 74.2% | |
| Dec. 31, 2023 | $-16.05 | $-12.35 | -30.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.3K | · | · | · | · | · | $0 | $0 | |
| Cost of Revenue | $693.7K | · | · | · | · | · | · | · | |
| Gross Profit | $-657.4K | · | · | · | · | · | · | · | |
| R&D Expense | $925.5K | $903.9K | $5M | $9M | $17M | $6M | $9M | $6M | |
| SG&A Expense | $6M | $15M | $11M | $12M | $18M | $7M | $6M | $7M | |
| Operating Expenses | $6M | $16M | $16M | $13M | $59M | $26M | $15M | $13M | |
| Operating Income | $-7M | $-16M | $-16M | $-13M | $-59M | $-26M | $-15M | $-13M | |
| Interest Expense | · | · | $22.5K | $15.9K | $11.2K | $6M | $433.9K | $101.8K | |
| Interest Income | · | · | $2.5K | $8.4K | $1.2K | $484 | $0 | · | |
| Other Non-op | $934.3K | $1.4K | $-4.2K | $-232.7K | $-3.3K | $0 | · | · | |
| Pretax Income | $-7M | $-16M | · | · | · | $-33M | $-15M | · | |
| Income Tax | $-398.7K | · | · | · | $0 | $0 | $0 | · | |
| Net Income | $-6M | $-18M | $-16M | $-15M | $-59M | $-33M | $-15M | $-14M | |
| EPS (Basic) | $-4.16 | $-15.99 | $-47.88 | $-416.94 | $-1988.53 | $-14.68 | · | · | |
| EPS (Diluted) | $-4.16 | $-15.99 | $-47.88 | $-416.94 | $-1988.53 | $-14.68 | · | · | |
| Shares (Basic) | 1,616,705 | 1,144,978 | 336,342 | 35,912 | 42,503 | 2,843,629 | · | · | |
| Shares (Diluted) | 1,616,705 | 1,144,978 | 336,342 | 35,912 | 42,503 | 2,843,629 | · | · | |
| EBITDA | $-7M | $-16M | $-16M | $-13M | · | $-26M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $899.8K | $163.5K | $4M | $1M | $8M | $6M | $175.8K | $1M | |
| Receivables | $30.0K | $0 | · | $93.0K | $0 | $551.5K | $3M | $3M | |
| Prepaid Expense | $110.9K | $145.3K | $1M | $2M | $1M | $1M | $595.2K | $513.0K | |
| Other Current Assets | $246.1K | · | · | · | · | · | · | · | |
| Current Assets | $3M | $83M | $5M | $3M | $9M | $8M | $3M | $5M | |
| PP&E (Net) | · | · | $14.6K | $43.8K | $73.1K | $18.3K | $77.4K | $128.9K | |
| PP&E (Gross) | $87.8K | $87.8K | $87.8K | $87.8K | $87.8K | $56.7K | $340.9K | $332.2K | |
| Accum. Depreciation | $87.8K | $87.8K | $73.3K | $44.0K | $14.7K | $38.4K | $263.5K | $203.4K | |
| Goodwill | $24M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | $22M | $338.4K | · | · | $0 | $3M | · | · | |
| Other Non-current Assets | · | · | · | · | $2M | $5M | · | · | |
| Total Assets | $49M | $85M | $7M | $5M | $12M | $13M | $9M | $7M | |
| Accounts Payable | $3M | $3M | $554.3K | $720.0K | $3M | $2M | $2M | $2M | |
| Accrued Liabilities | $1M | $252.0K | $825.3K | $320.2K | $393.3K | $127.0K | $71.2K | $285.1K | |
| Short-term Debt | $2M | · | $612.8K | $603.5K | $641.2K | $552.4K | $444.4K | $255.0K | |
| Current Liabilities | $15M | $28M | $3M | $2M | $12M | $16M | $4M | $3M | |
| Capital Leases | · | $59.0K | $146.9K | $214.1K | $311.1K | $19.1K | $0 | $0 | |
| Deferred Tax | $5M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $7M | $19.1K | $0 | $0 | |
| Total Liabilities | $20M | $28M | $3M | $3M | $20M | $16M | $4M | $3M | |
| Total Debt | $2M | · | $612.8K | $603.5K | · | $552.4K | · | · | |
| Common Stock | $422 | $159 | $156 | $5 | $7 | $312 | $2.7K | $1.8K | |
| Paid-in Capital | $229M | $199M | $188M | $171M | $147M | $94M | $69M | $53M | |
| Retained Earnings | $-209M | $-202M | $-184M | $-169M | $-154M | $-95M | $-63M | $-48M | |
| AOCI | $39.0K | · | · | · | $-1M | $-1M | $-1M | $-1M | |
| Stockholders' Equity | $25M | $-4M | $4M | $3M | $-8M | $-3M | $5M | $4M | |
| Liabilities + Equity | $49M | $85M | $7M | $5M | $12M | $13M | $9M | $7M | |
| Shares Outstanding | 4,224,146 | 1,584,650 | 1,560,998 | 49,750 | 70,742 | 3,115,030 | 26,800,519 | 17,704,925 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $574.7K | $48.9K | $29.3K | $29.0K | $15.0K | $38.0K | $63.1K | · | |
| Stock-based Comp | $734.0K | $631.6K | $1M | $769.1K | $1M | $522.1K | $574.3K | $1M | |
| Amort. of Intangibles | · | · | · | · | $528.0K | $528.0K | $780.0K | $736.5K | |
| Other Non-cash | $-618.8K | $8M | $2M | $-9M | · | $21M | · | · | |
| Operating Cash Flow | $-6M | $-9M | $-12M | $-22M | $-32M | $-11M | $-14M | $-11M | |
| CapEx | · | · | · | · | $69.5K | $4.2K | $24.1K | $55.5K | |
| Investing Cash Flow | $323.5K | $88.2K | $-500.0K | · | $-10M | $87.3K | $-24.1K | $-305.5K | |
| Stock Issued | · | · | · | · | $14M | $988.3K | $9M | · | |
| Net Stock Activity | · | · | · | · | · | $988.3K | · | · | |
| Financing Cash Flow | $6M | $6M | $15M | $16M | $45M | $17M | $13M | $12M | |
| Net Change in Cash | $714.8K | $-4M | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-11M | · | · | |
| Levered FCF | · | · | · | · | · | $-17M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -1813.6% | · | · | · | · | · | · | · | |
| Operating Margin | -19540.0% | · | · | · | · | · | · | · | |
| Net Margin | -17634.4% | · | · | · | · | · | · | · | |
| Pretax Margin | -18316.8% | · | · | · | · | · | · | · | |
| EBITDA Margin | -17954.6% | · | · | · | · | · | · | · | |
| ROA | -9.5% | -39.1% | -256.3% | -169.8% | · | -299.4% | · | · | |
| ROE | -68.6% | -804.0% | -459.0% | -6331.8% | · | -572.0% | · | · | |
| ROIC | -24.7% | · | · | · | · | 1265.8% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | 3.0 | 1.6 | 1.4 | · | 0.5 | · | · | |
| Quick Ratio | 0.1 | 0.0 | 1.2 | 0.6 | · | 0.4 | · | · | |
| Debt / Equity | 0.1 | · | 0.2 | 0.2 | · | -0.2 | · | · | |
| Interest Coverage | · | · | -702.1 | -798.4 | · | -4.5 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.6 | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.90 | $-0.82 | $2.31 | $2.76 | · | $-0.08 | · | · | |
| Revenue / Share | $0.02 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.53 | $-2.68 | $-36.80 | $-31.11 | · | · | · | · | |
| Cash / Share | $0.21 | $0.03 | $2.38 | $1.37 | · | $0.19 | · | · | |
| EPS (TTM) | $-4.16 | $-5.33 | $-47.88 | $-416.94 | $-1988.53 | $-14.68 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $36.3K | · | · | · | · | · | $0 | $0 | |
| Net Income TTM | $-6M | $-18M | $-16M | $-15M | $-59M | $-33M | $-15M | $-14M | |
| Market Cap | $20M | $9M | $20M | $366M | · | $3.81T | · | · | |
| Enterprise Value | $21M | · | $17M | $365M | · | $3.81T | · | · | |
| P/E | -1.1 | -0.4 | -0.3 | -0.9 | -9.2 | -8325.6 | · | · | |
| P/S | 543.0 | · | · | · | · | · | · | · | |
| P/B | 0.8 | -2.3 | 5.5 | 133.5 | · | -1441739.3 | · | · | |
| P / Tangible Book | · | · | 10.3 | 346.0 | · | · | · | · | |
| P / Cash Flow | -3.5 | -1.0 | -1.6 | -16.4 | · | -339275.3 | · | · | |
| P / FCF | · | · | · | · | · | -339149.4 | · | · | |
| EV / EBITDA | -3.2 | · | -1.1 | -28.9 | · | -144294.8 | · | · | |
| EV / FCF | · | · | · | · | · | -339148.9 | · | · | |
| EV / Revenue | 574.1 | · | · | · | · | · | · | · | |
| Earnings Yield | -89.3% | -285.6% | -380.0% | -113.3% | -10.9% | -0.01% | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Revenue | $85.9K | $38.2K | |
| Cost of Revenue | $122.4K | $651.9K | |
| Gross Profit | $-36.5K | $-613.7K | |
| R&D Expense | $8.4K | $631.4K | |
| SG&A Expense | $3M | $2M | |
| Operating Expenses | $13M | $3M | |
| Operating Income | $-13M | $-4M | |
| Other Non-op | $398.4K | $400.3K | |
| Pretax Income | $-13M | $-4M | |
| Income Tax | $-55.5K | $-297.6K | |
| Net Income | · | $-3M | |
| EPS (Basic) | $-2.01 | $-0.82 | |
| EPS (Diluted) | $-2.01 | $-0.82 | |
| Shares (Basic) | 6,419,222 | 4,451,298 | |
| Shares (Diluted) | 6,419,222 | 4,451,298 | |
| EBITDA | $-13M | $-4M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Cash & Equivalents | $1M | $385.5K | |
| Receivables | $79.6K | $41.3K | |
| Prepaid Expense | $468.1K | $320.2K | |
| Current Assets | $2M | $3M | |
| PP&E (Gross) | $87.8K | $87.8K | |
| Accum. Depreciation | $87.8K | $87.8K | |
| Goodwill | $14M | $24M | |
| Intangibles | $21M | $21M | |
| Total Assets | $37M | $48M | |
| Accounts Payable | $2M | $4M | |
| Accrued Liabilities | $1M | $1M | |
| Short-term Debt | $2M | $2M | |
| Current Liabilities | $14M | $16M | |
| Deferred Tax | $4M | $4M | |
| Total Liabilities | $18M | $20M | |
| Total Debt | $2M | $2M | |
| Common Stock | $691 | $611 | |
| Paid-in Capital | $240M | $231M | |
| Retained Earnings | $-225M | $-212M | |
| AOCI | $-333.8K | $49.3K | |
| Stockholders' Equity | $15M | $24M | |
| Liabilities + Equity | $37M | $48M | |
| Shares Outstanding | 6,913,198 | 6,108,264 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Stock-based Comp | $582.5K | $742.3K | |
| Amort. of Intangibles | $549.4K | $600.0K | |
| Operating Cash Flow | $-2M | $-2M | |
| Financing Cash Flow | $3M | $1M | |
| Net Change in Cash | $994.2K | $-514.2K |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Gross Margin | -42.5% | -1606.3% | |
| Operating Margin | -15262.4% | -9460.1% | |
| Net Margin | · | -8999.9% | |
| Pretax Margin | -15249.6% | -9778.9% | |
| EBITDA Margin | -15262.4% | -9460.1% | |
| ROA | · | -5.2% | |
| ROE | · | -37.4% | |
| ROIC | -78.8% | -12.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Current Ratio | 0.2 | 0.2 | |
| Quick Ratio | 0.1 | 0.0 | |
| Debt / Equity | 0.1 | 0.1 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | |
| Receivables Turnover | 1.1 | 1.2 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Book Value / Share | $2.15 | $3.86 | |
| Revenue / Share | $0.01 | $0.01 | |
| Cash Flow / Share | · | $-0.40 | |
| Cash / Share | $0.20 | $0.06 | |
| EPS (TTM) | $-6.50 | $-4.72 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Net Income TTM | $-9M | $-9M | |
| Market Cap | $32M | $12M | |
| Enterprise Value | $33M | $14M | |
| P/E | -0.7 | -0.4 | |
| P/B | 2.2 | 0.5 | |
| P / Cash Flow | · | -6.9 | |
| Earnings Yield | -138.6% | -233.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $36.3K | · | · | · | · |
| Gross Margin % | -1813.6% | · | · | · | · |
| Operating Margin % | -19540.0% | · | · | · | · |
| Net Income | $-6M | $-18M | $-16M | $-15M | $-59M |
| Diluted EPS | $-4.16 | $-15.99 | $-47.88 | $-416.94 | $-1988.53 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.1 | · | 0.2 | 0.2 | · |
| Current Ratio | 0.2 | 3.0 | 1.6 | 1.4 | · |
| Quick Ratio | 0.1 | 0.0 | 1.2 | 0.6 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 20 filers · $3.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
20
Value held
$3.0M
New positions
7
Exited positions
2
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (+1 vs prior Q) | 2 (0 vs prior Q) | 6 (+2 vs prior Q) | 3 (+2 vs prior Q) | +290K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $826,847 | 176,300 | 27.61% | Shares |
| CITADEL ADVISORS LLC | $400,174 | 85,325 | 13.36% | Shares |
| Federation des caisses Desjardins du Quebec | $358,082 | 76,350 | 11.96% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $347,341 | 74,060 | 11.60% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $280,925 | 59,899 | 9.38% | Shares |
| JANE STREET GROUP, LLC | $230,917 | 49,236 | 7.71% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $158,541 | 33,804 | 5.29% | Shares |
| STATE STREET CORP | $109,962 | 23,446 | 3.67% | Shares |
| VANGUARD GROUP INC | $100,871 | 21,646 | 3.37% | Shares |
| Independent Advisor Alliance | $70,350 | 15,000 | 2.35% | Shares |
| NORTHERN TRUST CORP | $65,374 | 13,939 | 2.18% | Shares |
| HARBOUR INVESTMENTS, INC. | $27,493 | 5,862 | 0.92% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $8,820 | 2,000 | 0.29% | Shares |
| Tower Research Capital LLC (TRC) | $6,777 | 1,445 | 0.23% | Shares |
| BARCLAYS PLC | $1,782 | 380 | 0.06% | Shares |
| SBI Securities Co., Ltd. | $145 | 31 | 0.00% | Shares |
| HRT FINANCIAL LP | $98 | 20,963 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $98 | 21 | 0.00% | Shares |
| DANSKE BANK A/S | $5 | 1 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $4 | 1 | 0.00% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Jason David Sawyer | July 8, 2026 | 7.10% | Initial filing | Passive investment | SEC |
| Ali Arif Nasir, Arif Ali IRA Roth, ANARP LLC, ANANRA LLC TRUST ×2 filings | June 10, 2025 | 4.90% | Amendment | · | SEC |
| Edmund Burke Ross Jr., EBR Ventures, LLC, ADEC Private Equity Investments, LLC ×6 filings | Feb. 10, 2021 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 21 insiders · 8 officers · 15 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jason David Sawyer | Chief Executive Officer | June 30, 2026 A | 540,000 | 0 | 0 | $0 |
| James Sapirstein | Chairman and CEO | July 2, 2024 S | 35,816 | 0 | 0 | $0 |
| Anna Skowron | Interim CFO | Dec. 22, 2025 A | 65,000 | 0 | 0 | $0 |
| Sarah Romano | Chief Financial Officer | Jan. 6, 2025 S | 17,287 | 0 | 0 | $0 |
| Daniel H Schneiderman | CHIEF FINANCIAL OFFICER | Jan. 3, 2022 A | · | 0 | 0 | $0 |
| Maged Shenouda | CHIEF FINANCIAL OFFICER | Dec. 28, 2018 P | 62,500 | 0 | 0 | $0 |
| James Pennington | CHIEF MEDICAL OFFICER | Jan. 3, 2022 A | · | 0 | 0 | $0 |
| Daniel Dupret | CHIEF SCIENTIFIC OFFICER | July 12, 2018 A | 15,000 | 0 | 0 | $0 |
| Geordan Garrett Pursglove | Director | Jan. 1, 2026 A | 40,000 | 0 | 0 | $0 |
| Manpreet Uppal | Director | Jan. 1, 2026 A | 40,000 | 0 | 0 | $0 |
| Jack Syage | Director | Jan. 1, 2026 A | 40,000 | 0 | 0 | $0 |
| Edward Borkowski | Director | Jan. 1, 2026 A | 60,248 | 0 | 0 | $0 |
| Chaitan Khosla PHD | Director | June 11, 2024 A | 24,889 | 0 | 0 | $0 |
| Mary Theresa Coelho | Director | Jan. 2, 2024 A | 20,237 | 0 | 0 | $0 |
| Alastair Riddell | Director | Jan. 2, 2024 A | 20,240 | 0 | 0 | $0 |
| Charles J Casamento | Director | Jan. 2, 2024 A | 19,937 | 0 | 0 | $0 |
| David Andrew Hoffman | Director | Jan. 3, 2023 A | 90,778 | 0 | 0 | $0 |
| Gregory Oakes | Director | Jan. 3, 2022 A | · | 0 | 0 | $0 |
| Vern Lee Schramm | Director | Jan. 3, 2022 A | 90,498 | 0 | 0 | $0 |
| Johan M. Spoor | Director | April 6, 2020 A | 338,617 | 0 | 0 | $0 |
| Edmund Burke Ross Jr. | 10% owner | Jan. 2, 2020 J | 2,540,555 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
GRDX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 6 analysts
SELL
0 0.0%
Strong Buy
0 0.0%
Buy
3 50.0%
Hold
1 16.7%
Sell
2 33.3%
Strong Sell
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| GRDX | $20M | -1.1 | · | -17634.4% | -68.6% | -1813.6% |
| MCRB | $142M | 23.2 | · | 721.9% | 14.8% | · |
| ATYR | $77M | -1.0 | -19.1% | -39009.5% | -107.8% | · |
| RNAZ | · | -0.1 | · | · | · | · |
| SHPH | $4M | -0.3 | 0.00% | · | -400.1% | · |
| KYNB | $36M | 0.2 | -78.3% | 2848.6% | -143.5% | · |
| ATOS | $5M | -0.1 | · | · | -71.7% | · |
| NXTC | $50M | -0.7 | · | · | -172.9% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q/A filed Sep 18, 2026